Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired platelet dysfunction.

Yu-Min P Shen1, Eugene P Frenkel

  • 1The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-8852, USA. yu-min.shen@utsouthwestern.edu

Hematology/Oncology Clinics of North America
|August 2, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tailoring caplacizumab administration using ADAMTS13 activity for immune-mediated thrombotic thrombocytopenic purpura.

Blood vessels, thrombosis & hemostasis·2025
Same author

Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.

Annals of hematology·2022
Same author

Utilization of emicizumab in acquired hemophilia A: A case report.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2022
Same author

Total Methionine Restriction Treatment of Cancer.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients.

Neoplasia (New York, N.Y.)·2017
Same author

Academic Cancer Center Phase I Program Development.

The oncologist·2017
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Acquired platelet dysfunction, often caused by medications or disorders, impairs platelet aggregation, adhesion, or secretion, leading to bleeding. This review covers common causes and clinical presentations of platelet function disorders.

Area of Science:

  • Hematology
  • Clinical Medicine
  • Platelet Physiology

Background:

  • Acquired platelet dysfunction is a common clinical issue.
  • Manifestations include mucosal bleeding, epistaxis, and superficial epidermal bleeds.
  • Causes are often linked to medications or systemic disorders.

Purpose of the Study:

  • To review acquired platelet dysfunction.
  • To discuss decreased platelet aggregation, adhesion, or secretion.

Main Methods:

  • Literature review of acquired platelet dysfunction.
  • Analysis of platelet function mechanisms.

Main Results:

  • Platelet dysfunction affects adhesion, shape change, secretion, and aggregation.

Related Experiment Videos

  • Common causes include medications and systemic diseases.

    • Conclusions:

    • Understanding acquired platelet dysfunction is crucial for managing bleeding.
    • This review provides insight into various forms of platelet dysfunction.